Poster 19: Compressive Optic Neuropathy in Low-Tension Glaucoma Suspect

Author(s):  
Kevin Talaga ◽  
David Reed
2021 ◽  
pp. 112067212199104
Author(s):  
Catherine J Hwang ◽  
Erin E Nichols ◽  
Brian H Chon ◽  
Julian D Perry

Thyroid eye disease is an auto-immune mediated orbitopathy which can cause dysthyroid compressive optic neuropathy. Traditional management of active thyroid eye disease includes temporizing high-dose steroids, orbital radiation and surgical decompression, which each possess significant limitations and/or side effects. Teprotumumab is an IGF-IR inhibitor recently FDA-approved for active thyroid eye disease. The authors report reversal of bilateral dysthyroid compressive optic neuropathy managed medically utilizing teprotumumab.


2011 ◽  
Vol 35 (2) ◽  
pp. 78-80
Author(s):  
Niranjan Pehere ◽  
C. Anjaneyulu ◽  
Ruchi Mittal ◽  
Geeta Vemuganti

2011 ◽  
Vol 90 (2) ◽  
pp. e132-e137 ◽  
Author(s):  
Luca Agnifili ◽  
Paolo Carpineto ◽  
Vincenzo Fasanella ◽  
Rodolfo Mastropasqua ◽  
Antonio Zappacosta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document